EFFECTS OF VISCOELASTIC PROPERTIES AND HYDRATION KINETIC ON DRUG RELEASE FROM THE TABLET OF DICLOFENAC SODIUM BASED ON POLY (SODIUM ACRYLATE)-GRAFTED-GELLAN MATRIX
Investigation of the effects of viscoelasticity and hydration kinetic on the drug release behavior from the poly (sodium acrylate)-grafted-gellan matrix (PSAc-g-GG) was the main objective of this study. At first, poly (acrylic acid)-grafted-gellan was treated with 0.05M NaOH to obtain poly (sodium acrylate)-grafted-gellan followed by its purification and subsequent lyophilicity study and viscoelastic study on PSAc-g-GG with different degree of grafting. The study revealed that the degree of grafting greatly affects the viscoelastic and rheologic characteristics of the copolymer, which further affect the drug release profile from the polymeric matrix. The copolymer with highest grafting (626.3%) exhibited much higher starting % strain (17.79%), stress (53.7 Pa) for structural breakdown at Gꞌ= Gꞌꞌ (214.4 Pa), higher storage modulus (G’), much greater values of complex viscosity (11.5 Pa.s) and cross-over point (Gꞌ= Gꞌꞌ =271.65 Pa) compared to that of the batch of copolymer with lower grafting. The water uptake index (%WE) was found to be directly proportional to the percentage grafting (%G), whereas the batches with higher grafting revealed lower initial swelling rate representing its inversely proportional relation to %grafting in case of 0.1N HCl acid. Equilibrium swelling and hydration were also found to be proportional to % grafting. The similar effect was observed in phosphate buffer solution (pH 6.8) with an exception that the degree of the swelling parameters obtained from phosphate buffer was very much greater compared to that found in 0.1N HCl. PSAc-g-GG exhibited extended drug release over a period of 10 hours with the drug release mechanism based on Case-1 Fickian diffusion or square root of time kinetic. The study also exhibited the usefulness of viscoelastic and swelling study in order to identify the effects of the degree of grafting on the drug release.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).